Previous studies showed that ghrelin level is lower in individuals showing obesity, insulin resistance, or metabolic syndrome [12–14], and all these conditions were proven to be risk factors for cognitive decline in T2DM subjects [15, 16]. The gene discussed is GHRL; the disease is metabolic syndrome.